US Patent Issued to Flex Pharma on Oct. 6 for "Amorphous nilotinib microparticles and uses thereof" (Minnesota Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,950, issued on Oct. 6, was assigned to Flex Pharma LLC (New Brighton, Minn.).

"Amorphous nilotinib microparticles and uses thereof" was invented by Christian F. Wertz (Saint Louis Park, Minn.), Tzehaw Chen (Cocoran, Minn.) and Joseph McTarsney (Shakopee, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Amorphous solid dispersions and pharmaceutical compositions of the protein kinase inhibitor nilotinib. The pharmaceutical compositions may be used in methods of treating a proliferative disorder such as cancer. In some embodiments, the pharmaceutical compositions can be administered without regard to food consumption. In other embodiments, the phar...